COPD Maintenance Therapy
Links shared publicly online about this topic
COPD Maintenance Drug Approved by FDA | ThirdAge
thirdage.com — “The FDA approved the first oral anti-inflammatory treatment for chronic obstructive pulmonary disease. The once-a-day tablet, DalirespTM (roflumilast), helps reduce lung functions for OCPD patients who experience breathlessness, chronic cough and” View full resource at thirdage.com
Most Recently Shared on March 1, 2011 at 9:00 pm By:
COPD Maintenance Drug Approved by FDA http://bit.ly/eJUK5k
Maintenance
examiner.com — “Maintenance” View full resource at examiner.com
Most Recently Shared on July 30, 2010 at 3:38 am By:
Peter H Brown Doctor and Psychologist
Asking Ann About Autism: Interactive Metronome Therapy (slide show) http://exm.nr/d9LEYV #autism
Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 5:28 pm By:
FDA Okays COPD Maintenance Drug http://bit.ly/hLPY5J
Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 4:50 pm By:
allergydropz ENT Doctor, Physician, Doctor, and Surgeon
Medpage Today: FDA Okays COPD Maintenance Drug http://bit.ly/hbVv4V Full http://bit.ly/emdYZW
Asthma and COPD Therapy | SYMBICORT® (budesonide/formoterol fumarate dihydrate)
symbicorttouchpoints.com — “Find information on asthma and COPD maintenance therapy with SYMBICORT (budesonide/formoterol fumarate dihydrate).” View full resource at symbicorttouchpoints.com
Most Recently Shared on October 8, 2010 at 3:26 pm By:
Walter Jessen - Highlight HEALTH Health Organization and Health Executive
Symbicort (budesonide/formoterol fumarate dehydrate) [Highlight HEALTH Web Directory] http://ow.ly/19lVGt
Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, th” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 10:11 pm By:
New Inhaler Drug for COPD Approved http://bit.ly/mdZsWr
Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, th” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 10:13 pm By:
allergydropz ENT Doctor, Physician, Doctor, and Surgeon
Medpage Today: New Inhaler Drug for COPD Approved http://bit.ly/kTxsDs Full http://bit.ly/iZucPv
ingentaconnect Triple Therapy for the Management of COPD: A Review
ingentaconnect.com — “ingentaconnect Triple Therapy for the Management of COPD: A Review” View full resource at ingentaconnect.com
Most Recently Shared on June 9, 2011 at 12:26 pm By:
Juan C. Ivancevich, MD Allergist, Physician, Doctor, and Internist
COPD: There is insufficient evidence to determine if triple therapy is superior to dual bronchodilator therapy http://bit.ly/kNGfkH
Respiratory Therapy Cave: What is severe COPD?
respiratorytherapycave.blogspot.com — “Respiratory Therapy Cave: What is severe COPD?” View full resource at respiratorytherapycave.blogspot.com
Most Recently Shared on March 26, 2010 at 2:06 pm By:
Rick Frea Patient Expert and Health Professional
What is severe COPD?: http://bit.ly/9p3pOr via @addthis
Physician's Weekly Article - Antibiotic Therapy & COPD Exacerbations
physweeklyarchives.com — “Physician's Weekly, your source for medical news, information on new drugs and devices, clinical updates, CME accreditation for radiology, emergency medicine, pediatrics, mammography, and anesthesia .” View full resource at physweeklyarchives.com
Most Recently Shared on September 9, 2010 at 9:25 pm By:
Antibiotic Therapy & COPD Exacerbations - A Massachusetts research group has found that early antibiotic administrat... http://ow.ly/18WgAy
Medical News: Triple Therapy Reduces COPD Exacerbations - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “For moderate-to-severe chronic obstructive pulmonary disease (COPD), a triple regimen of a long-acting β-agonist (LABA), an inhaled corticosteroid, and an antimuscarinic agent substantially cuts” View full resource at medpagetoday.com
Most Recently Shared on October 8, 2009 at 7:21 pm By:
Triple Therapy Reduces COPD Exacerbations (CME/CE) http://ow.ly/15TGWI
COPD Foundation Blog
blog.copdfoundation.org — “The mission of the COPD Foundation is to develop and support programs which improve the quality of life through research, education, early diagnosis, and enhanced therapy for persons whose lives are impacted by Chronic Obstructive Pulmonary Disease.” View full resource at blog.copdfoundation.org
Most Recently Shared on April 5, 2010 at 3:20 pm By:
COPD Foundation Health Organization
Thx 4 the shout-out Geoff! Ur da bomb! RT @geoffliving Check it out! @copdfoundation launches its blog today! http://blog.copdfoundation.org
New Inhaler Drug for COPD Approved - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, the agency announced.” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 11:00 pm By:
New Inhaler Drug for COPD Approved: WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol... http://bit.ly/iGWeAq
PharmaTelevision - COPD Therapies, PTV News: May 12, 2010
pharmatelevision.com — “PharmaTelevision - COPD Therapies, PTV News: May 12, 2010” View full resource at pharmatelevision.com
Most Recently Shared on May 12, 2010 at 12:06 pm By:
COPD Therapies, PTV News: May 12, 2010: Galapagos and Roche expand their alliance to develop "smokers lung" drugs http://tinyurl.com/35m63w9
Combination Therapy Options in Stable COPD - QualityPoint Technologies
qualitypointtech.net — “Which long-acting muscarinic antagonist improves outcomes in COPD? U.S. Pharmacist” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 4:09 pm By:
Combination Therapy Options in Stable COPD: Which long-acting muscarinic antagonist improves outcomes in COPD? U.... http://bit.ly/bbOEAN
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
ThirdAge.com
A boomer's guide to a life of health, happiness, passion & purpose.
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
Advertisement
